Category Archives: HIV/AIDS

COVID-19: In Maryland and across America, disparate outcomes show impacts of inequities

By on .

Allison Agwu, M.D., ScM is an associate professor of Adult and Pediatric Infectious Diseases at Johns Hopkins University School of Medicine in Baltimore, Maryland. She cares for patients across the age spectrum, in both the pediatric and adult Ryan-White funded HIV clinics at Johns Hopkins, as the founder and medical director of the Accessing Care […]

COVID-19: In Amb. Birx, the White House gets a scientist, physician, public health expert and global health realist as response coordinator

By on .

If the criteria for the selection announced Wednesday night of Vice President Mike Pence to lead the U.S. efforts to contain the spread of COVID-19 seemed less than obvious to public health experts, another appointment announced today may bring a measure of reassurance. Mr. Pence faced criticism in his most prominent previous role in a […]

As an opioid crisis drives the spread of HIV, Kentucky plan invests in harm reduction, training, care and community

By on .

Using funds generated by Kentucky’s HIV drug assistance program, a plan launched this month will support urgent and ongoing responses to the infectious disease impacts of an injecting drug use epidemic From all the evidence that Dr. Alice Thornton and her colleagues could see in the growing numbers of patients coming through the doors of […]

USAID brief on hormonal contraception: While questions remain, women at high risk and with HIV can use all available methods

By on .

While evidence of a tie between some injectable hormonal contraceptives and an increased risk of HIV acquisition remains incomplete, that potential risk must be balanced against the life-saving benefits of preventing unintended pregnancy, a brief from USAID’s Office of Population and Reproductive Health says. The brief, prepared in collaboration with the U.S. President’s Emergency Plan […]

Agreement on HIV-blindness medicine hoped to increase treatment, diagnosis — and add to understanding of late ARV access impact

By on .

Faded from memory in developed countries since the advent of antiretroviral treatment, and under-diagnosed in low- and middle-income countries where treatment has remained out of reach for many, cytomegalovirus retinitis, the disease that causes HIV-related blindness, has been called the neglected opportunistic infection of the AIDS pandemic. A recently released study suggests the scope of […]

More complete data on PEPFAR results needed, says second GAO treatment report

By on .

The second of two reports from the U.S. Government Accountability Office reviewing HIV treatment efforts suppported by the President’s Emergency Plan For AIDS Relief concludes that incomplete information on the results of those efforts will interfere with accurately evaluating partner countries’ abilities to sustain treatment programs. The GAO also has produced a report on PEPFAR […]

Study’s yield could extend reach of HPV vaccine, but probably not where need is greatest

By on .

Administered before girls start  having sex, vaccines against the human papillomavirus — HPV — offer their greatest protection against infections that can lead to cervical cancer. Since the vaccination can only prevent infection, the benefits after the start of sex  — to individual girls and women, as well as to public health — diminish in […]

Analysis looks at fiscal savings, human toll

By on .

Unless Congress finds ways to lower the federal deficit by $1.2 trillion in the next five months,  the law passed last year mandating across-the-board cuts to nearly all budget items will reduce current global health spending by about 10 percent of its current level, an analysis by the Foundation for AIDS Research (amfAR) estimates. The […]

Further budget analysis from Global Center

By on .

Yesterday we received more information about the budget proposal from President Obama.  There are some new details, such as his proposal to flat-fund US backing for the Global Fund.  His proposal does not add up, I am sorry to say, and it is not consistent with the Hyde-Lantos legislation the President co-sponsored last year.  Why […]

The 63 Billion Dollar Question

By on .

This week the Obama Administration seemed to take a page from George Bush’s old playbook as the new Administration announces a very big sounding figure, $63 billion, for global health programs that help poor countries — when, in fact, the proposal obscures the real facts about the Obama budget, especially for FY 2010.